- Home
- SMHI vs CATX Comparison
SMHI vs CATX Comparison
Compare SMHI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMHI | CATX |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.8M | 609.4M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SMHI | CATX |
|---|---|---|
| Price | $7.67 | $5.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.89 |
| AVG Volume (30 Days) | 159.0K | ★ 1.5M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.41 | 29.31 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $173,783,000.00 | N/A |
| Revenue This Year | $1.07 | N/A |
| Revenue Next Year | $6.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.63 | $1.60 |
| 52 Week High | $8.17 | $6.16 |
Technical Indicators
Market Signals| Indicator | SMHI | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 56.66 |
| Support Level | $5.87 | $3.24 |
| Resistance Level | $7.88 | $5.39 |
| Average True Range (ATR) | 0.45 | 0.39 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 60.10 | 40.27 |
Price Performance
Historical ComparisonAbout SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.